GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (HAM:BBZA) » Definitions » Cyclically Adjusted PS Ratio

BB Biotech AG (HAM:BBZA) Cyclically Adjusted PS Ratio : (As of Jul. 19, 2025)


View and export this data going back to 2008. Start your Free Trial

What is BB Biotech AG Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


BB Biotech AG Cyclically Adjusted PS Ratio Historical Data

The historical data trend for BB Biotech AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Cyclically Adjusted PS Ratio Chart

BB Biotech AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 6.77 7.08 4.03

BB Biotech AG Quarterly Data
Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.81 6.77 4.46 4.03 3.87

Competitive Comparison of BB Biotech AG's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, BB Biotech AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Cyclically Adjusted PS Ratio falls into.


;
;

BB Biotech AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

BB Biotech AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, BB Biotech AG's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-4.571/107.7224*107.7224
=-4.571

Current CPI (Mar. 2025) = 107.7224.

BB Biotech AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201209 11.186 101.392 11.884
201212 -9.504 100.968 -10.140
201303 25.914 101.221 27.578
201306 9.651 101.466 10.246
201309 3.919 101.336 4.166
201312 1.228 101.036 1.309
201403 0.809 101.224 0.861
201406 2.434 101.517 2.583
201409 5.966 101.247 6.348
201412 10.739 100.704 11.487
201503 6.404 100.339 6.875
201506 5.917 100.464 6.345
201509 -9.275 99.785 -10.013
201512 8.481 99.386 9.192
201603 -19.875 99.475 -21.523
201606 0.736 100.088 0.792
201609 6.706 99.604 7.253
201612 -0.382 99.380 -0.414
201703 6.351 100.040 6.839
201706 1.880 100.285 2.019
201712 0.000 100.213 0.000
201812 0.000 100.906 0.000
201912 0.000 101.063 0.000
202012 0.000 100.241 0.000
202103 3.639 100.800 3.889
202106 2.363 101.352 2.512
202112 0.000 101.776 0.000
202203 -5.272 103.205 -5.503
202206 -3.938 104.783 -4.048
202209 4.170 104.835 4.285
202212 -0.621 104.666 -0.639
202303 -4.639 106.245 -4.704
202306 -0.085 106.576 -0.086
202309 -0.780 106.570 -0.788
202312 2.149 106.461 2.174
202403 4.951 107.355 4.968
202406 -1.515 107.991 -1.511
202409 -2.907 107.468 -2.914
202412 1.199 107.128 1.206
202503 -4.571 107.722 -4.571

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BB Biotech AG  (HAM:BBZA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


BB Biotech AG Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG Business Description

Industry
Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system.

BB Biotech AG Headlines

No Headlines